These starting doses help the body adjust gradually to treatment while reducing the likelihood of early digestive side effects
DOI: 10.1186/s12933-019-0857-6 [Google Scholar] Verma S, Mazer CD, Yan AT, Mason T, Garg V, Teoh H, et al
Lundbeck A/S, Janssen, Johnson & Johnson, King, Merck and Co., National Institute of Health (NIH), Neurim, Neurocrine Biosciences, Naurex, Neurim, Neurogen, Novo Nordisk, Organon, Orphan Medical, Otsuka, Pfizer, Predix, Respironics, Saladax, Sanofi-Aventis, Sanofi-Synthelabo, Schering-Plough, Sepracor, Sunovion, Shire, Somaxon, Takeda Pharmaceuticals North America, Targacept, Teva, Thymon, Transcept, UCB Pharma, Ultragenyx, Predix, Vanda, Wyeth-Ayerst Research
(2008) Exenatide effects over 3 years (PubMed) Frequently Asked Questions What are GLP-1 agonists
Weight loss widens your thermoregulatory tolerance window, reducing trigger frequency